Which of the following is NOT a therapeutic management for magnesium sulfate?

• A. Assess for pulmonary edema
• B. Chest pain assessment
• C. Neurovascular Assessment
• D. Increasing patient activity levels

Answer: (D)

In the context of magnesium sulfate therapy, particularly in obstetric care such as for preeclampsia or eclampsia, the primary focus is on monitoring the patient’s status and the effects of the medication. Therapeutic management of magnesium sulfate includes several important assessments and interventions to ensure patient safety and the drug's effectiveness.

Increasing patient activity levels is not a typical or therapeutically appropriate management step when a patient is receiving magnesium sulfate. This medication is often administered to relax the smooth muscles, provide neuroprotection to the fetus, and prevent seizures. During magnesium sulfate therapy, patients are usually advised to remain on bed rest or limit physical activity to reduce the risk of complications, such as falls or exacerbation of their condition.

On the other hand, assessing for pulmonary edema is crucial because magnesium sulfate can impact fluid balance, especially in patients with pre-existing conditions that may lead to fluid overload. Conducting a chest pain assessment is also relevant, given that certain cardiovascular issues can arise during treatment. Additionally, performing a neurovascular assessment is vital since magnesium sulfate acts as a central nervous system depressant, and monitoring neurological status ensures that the treatment is effective and that any adverse effects are promptly identified.

Thus, increasing patient activity levels does not align with